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Abstract
Overtraining syndrome (OTS) is characterized by an unexplainable drop in athletic 
performance. It affects primarily elite, endurance athletes, though sub-elite athletes are also 
affected. Although the deterioration in performance is often the most pronounced and 
troublesome symptoms for athletes, others range from severe fatigue and insomnia to depression 
and lack of mental concentration. There is no known diagnostic tool except for ruling out all 
other possible explanations for the abnormal performance. The only known remedy for OTS is 
rest. Some recover within months while others take a year or more. Some athletes never fully 
recovery and never return to pre-OTS performance levels.
The exact mechanism behind OTS is unknown. Consensus has been reached among exercise 
science professionals that 1) an imbalance between stress load and recovery leads to OTS; 2) 
OTS exists on a spectrum of possible outcomes from different exercise/rest ratios; and 3) 
exercise is only one part of systemic stress that can lead to OTS. In addition to physical exercise, 
other factors such as environmental conditions, family dynamics, schoolwork, job stressors, and 
social pressures all contribute to the total stress load on the body. A severe and sustained 
imbalance between stress and rest is a likely contributor to OTS in athletes.
I investigated biomarkers and psychological markers that, in concert, could be used to 
identify athletes who are at the greatest risk for developing OTS before the onset of symptoms. I 
examined vitamin D, cognitive function, and oxidative stress status in university cross country 
skiers in addition to athletic performance status during the competitive ski season. This study’s 
results support three primary conclusions. First, collegiate endurance athletes are more prone to 
vitamin D insufficiency and deficiency than their sedentary counterparts. Second, collegiate
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cross country ski racers in the circumpolar North are unlikely to maintain adequate vitamin D 
during a competition season. Furthermore, vitamin D levels are likely to drop in the post-season, 
recovery period. Third, cognitive function is likely to be significantly higher in the post-season 
than during the competition season. Fourth, those who experienced a drop in performance 
during the competition season are more likely to show signs of oxidative stress. These findings 
may help to produce a screening tool for OTS.
iv
Dedication
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General Introduction
The human body is able to respond to a stress response through adaptation and/or 
diversification by means of gene expression [1]. This adaptation to stimuli is, at the most basic 
level, the essence of physical exercise. When homeostasis is disrupted subsequent adaptation 
occurs. Exercise (“athletic training” or “training”) is based on this very principal: the body will 
adapt to stress to reach a new level of fitness -  a new state of homeostasis. Whether it is a child 
who decides to run to the market one day instead of walking, or a world class sprinter performing 
squat exercises with higher resistance, adaptation to physical stimuli is the nature of exercise and 
sport. Indeed, the motto of the modern Olympic Games, “Citius, Altius, Fortius”, captures the 
premise that the body can adapt to exercise and reach new levels of performance: “Faster,
Higher, Stronger” .
The process of stress and adaptation is not complete, however, without an adequate “resting” 
period or “recovery” state between exercise bouts [2]. The terms “rest and “recovery” may refer 
to several distinct conditions and processes. Recovery may indicate time between training 
sessions, specific physiological processes or conditions that are different than those found during 
exercise, or a cue indicating when exercise may resume again [2]. “Physiology of recovery”, a 
sub-discipline of exercise physiology, focuses on the period of time between the cessation of one 
bout of exercise and the commencement of the next [2]. While the field is evolving, one 
constant remains clear. Without adequate recovery from exercise the body will not adapt [3], 
making recovery as important for improved athletic performance as exercise itself.
Training and recovery are meshed together on a spectrum of possible, exercise-related 
outcomes. Hallmarks of this spectrum include functional overreaching (FO), non-functional 
overreaching (NFO), and overtraining (OT). FO is the normal overload, recovery, and super­
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compensation cycle required for improvement in athletic performance. NFO shares an overload 
feature with FO, but an ineffectual recovery period leads to stagnant performance. OT shares an 
overload period and ineffectual recovery with NFO. However, instead of a performance plateau, 
athletic performance declines with OT [4]. If OT persists, an athlete may succumb to 
overtraining syndrome (OTS).
OTS is characterized by an otherwise unexplainable drop in athletic performance. OTS 
affects both the sympathetic and parasympathetic nervous systems [5]. In addition to the decline 
in athletic performance, symptoms range from depression and bradycardia to insomnia and 
tachycardia (Table I.1). There is no universal diagnostic tool for OTS and many OTS symptoms 
can be caused by other factors such as endocrinological disorders, eating disorders, anemia, viral 
infections, and bacterial infections [4]. As such, a clinician must rule out these other possibilities 
for the decline in performance before considering OTS.
An athlete may experience NFO, OT, and OTS as he/she trains according to a comprehensive 
exercise plan that has worked in the past and/or works for other athletes of similar abilities. A 
plateau in performance and/or a drop in performance is not necessarily associated with a 
substantial increase in training load. Recovery is as important to increased athletic performance 
as exercise itself; therefore, some researchers and physicians refer to OTS as “underperformance 
syndrome” or “unexplained underperformance syndrome” (UUS) [6]. It is quite likely that the 
body which is not permitted to reach homeostasis before undergoing another exercise bout will 
not adapt effectively to the new stress. A disrupted homeostasis may have as much to do with 
factors outside of training -  family, school, relationships, work -  than with the actual physical 
stress of exercise [6].
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The most agreed upon treatment for OTS is rest, either Relative (some low intensity bouts of 
exercise) or Absolute (no exercise or other strenuous, physical exertion) depending on the 
severity [6]. Some evidence suggests that a high carbohydrate diet may prevent development of 
OTS, and speed recovery from OTS [4]. Other researchers have suggested that, owing to the 
similarities of neuroendocrinologic changes between depression and OTS, that a selective 
serotonin reuptake inhibitor (SSRI) may be an effective OTS treatment [5]. However, there is a 
danger of the development of heat stress with an SSRI, as well as decreased athletic performance 
with antidepressant medications [5]. Furthermore, SSRI usage for OTS is not FDA approved 
[6]. Recovery for most OTS athletes takes months [4] while some never fully recover [6].
While the “cause” of OTS seems relatively simple -  an imbalance between exercise and 
recovery -  the actual etiology has yet to be pinpointed. Several hypotheses exist, ranging from 
glycogen depletion to cytokine-induced, systemic inflammation (Table I.2) [5].
In addition to an unknown etiology, there is no known method to determine which athletes 
are at an increased risk of developing OTS. The overarching goal of my PhD research is to 
pinpoint physiological biomarkers and/or psychological markers that will, either singly or in 
concert, help predict who is at the greatest risk of developing OTS prior to the onset of 
symptoms. Finding markers of OTS would, theoretically, allow trainers and athletes to adjust 
training, rest, and lifestyle in a purposeful way to maximize performance and minimize risk of 
OTS. The difficulty of diagnosis and the ethical concerns of inducing OTS make it challenging 
to study. I chose to focus on vitamin D deficiency (Chapter 1 and 2), cognitive function 
(Chapter 2), and the oxidative stress hypothesis (Chapter 3). Initially I studied vitamin D in 
active university athletes and compared them to their sedentary counterparts to establish whether 
exercise compounded the risk of insufficiency and deficiency in the circumpolar North (Chapter
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1). After establishing the increased risk, I followed up with a second human subject study that 
monitored university athletes through training macrocycles to determine if biomarkers increased, 
decreased, or remained the same during the stressful competition season compared to one month 
of post-season recovery. Additional comparisons were made between participants who reported 
an unexplainable drop in performance lasting at least three weeks and those who did not.
Certain OTS symptoms, particularly a loss of mental concentration and muscle weakness, are 
similar to vitamin D deficiency symptoms. Most athletes with OTS (67%) have “total autonomic 
dystonia”, a maladaptation associated with depressed regulatory function of the autonomic 
nervous system, both sympathetic and parasympathetic [7]. A lack of concentration and 
depression are common symptoms among OTS athletes [5]. Vitamin D deficiency is linked to 
depressive symptoms [8] and decreased cognitive function [9], though the latter is more 
pronounced in the elderly.
There are two primary avenues by which humans receive vitamin D: cutaneous 
synthetization and ingestion. The former is the major source of vitamin D for most humans [10]. 
Diet can also contribute significantly. Certain naturally occurring foods, primarily oily fish such 
as mackerel and salmon, are rich in vitamin D. Some fungi and plants offer limited amounts of 
vitamin D. Fortified foods such as dairy products and some fruit juices also contribute to 
vitamin D intake. Oral vitamin D supplements of at least 800 IUs per day should provide 
vitamin D adequacy unless there are mitigating factors [11]. While this is a seemingly 
straightforward recommendation, vitamin D deficiency has been recognized as a worldwide 
pandemic [10].
Biosynthesized from cholesterol, 7-dehydrocholesterol is the precursor to vitamin D. The 
sun’s ultraviolet radiation converts 7-dehydrocholesterol in the skin to vitamin D3
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(cholecalciferol) which then undergoes two hydroxylations in the liver. First, D3 is hydroxylated 
to 25(OH)D3, then to 1,25(OH)2D3, the biologically active form of vitamin D [12].
Vitamin D2 (ergocalciferol) is found mainly in plants and fungi. When ingested, D2 can 
be converted for use, though it remains a relatively small source of naturally occurring vitamin D 
for most individuals. Vitamin D2 is hydroxylated twice in the liver in a similar fashion as D3. It 
is first converted to 25(OH)D2, then to 1,25(OH)2D2. Both 1,25(OH)2D3 and 1,25(OH)2D2 have 
the same functionality. Vitamin D 2 and vitamin D 3 are considered bioequivalent and both can be 
used effectively in supplements [13].
Prevalence of vitamin D deficiency is greater at higher latitudes [14]. During the winter 
months at locations above 35° latitude the zenith angle of the sun is more oblique which prevents 
few, if any, UVB rays from reaching the earth’s surface; the winter zenith angle of the sun 
severely limits or prevents vitamin D production in the skin [15]. High rates of vitamin D 
deficiency is also well documented among athletes [16, 17, 18]. Deficiency for many athletes 
follows a seasonal shift [16, 19, 20]. In a meta-analysis of 23 studies including 2,313 athletes, 
Farrokhyar et al. found 56% of athletes had vitamin D inadequacy that varied significantly by 
geographical location [21].
Considering the overlapping symptoms of OTS and vitamin D deficiency, vitamin D 
deficiency among athletes, and vitamin D deficiency in the circumpolar North, I chose to 
investigate vitamin D status as possible indicator of NFO and OT. Due to the implications of 
OTS and vitamin D deficiency on cognitive function, I also elected to examine basic hand-eye 
coordination in endurance athletes using the Purdue Pegboard Test (PPT).
The PPT is a simple test of cognitive function. The PPT involves three timed batteries in 
which participants place small metal pegs into holes. The sequence begins with the dominant
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hand, then the non-dominant hand, and finally both hands together. A fourth timed battery 
requires the participant to build small assemblies using a peg, a washer, a collar, and a second 
washer. A study of the PPT’s three trial, test-retest procedure demonstrated high reliability [22].
The oxidative stress hypothesis (OSH) of OTS contends that pathologic levels of 
oxidative stress can cause inflammation, muscle fatigue, and soreness which, in turn, results in a 
deterioration of athletic performance. In overtrained athletes, Tanskanen, Atalay, and Uusitalo 
found antioxidant protection against acute stress from exercise was impaired and resting 
oxidative stress increased [23]. In a study that overtrained humans for three weeks within a 12- 
week training cycle, Margonis et al. found that the high volume and intensity of exercise caused 
striking oxidative stress response [24]. Two markers of oxidative stress, catalase and glutathione 
peroxidase activity, increased significantly while total antioxidant capacity (TAC) dropped 
significantly. Although the OSH does not account for all OTS symptoms, the hypothesis is 
strong enough to justify further research. Therefore, I chose to examine markers of oxidative 
stress while, at the same time, surveying participants for relative athletic performance.
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Table 1.1. Symptoms of OTS
Parasympathetic Alterations Sympathetic Alterations Other
Fatigue Insomnia Anorexia
Depression Irritability Weight loss
Bradycardia Agitation Lack of mental concentration
Loss of motivation Tachycardia Heavy, sore, stiff muscles
Hypertension Anxiety
Restlessness Awakening unrefreshed
Adapted from Kreher & Schwartz, 2012.
Table I.2. Recognized hypotheses of OTS etiology.
Hypothesis Theory
Glycogen depletion ^  glycogen leads to: 
'h  fatigue 
^  performance
Central fatigue 'h  tryptophan uptake in brain leads to: 
'h  serotonin centrally 
'h  mood symptoms
Glutamine ^  glutamine leads to:
^  immune system function 
'h  infection susceptibility
Oxidative stress 'h  oxidative stress leads to: 
'h  fatigue 
'h  muscle damage
Autonomic nervous system 'h  parasympathetic control causes many symptoms of OTS
Hypothalamic Imbalance in the hypothalamus and hormonal axes cause 
many symptoms of OTS
Cytokine Inflammation and cytokine activation can account for most 
OTS symptoms
Adapted from Kreher & Schwartz, 2012.
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1 2Chapter 1: 25(OH)D levels in trained v. sedentary university students at 64° north ’
Abstract
Purpose -  25-hydroxyvitamin D (25[OH]D) deficiency is associated with compromised bone 
mineralisation, fatigue, suppressed immune function and unsatisfactory skeletal muscle recovery. 
We investigated the risk of 25(OH)D insufficiency or deficiency in endurance athletes compared 
to sedentary non-athletes living at 64° north.
Methods -  University student-athletes (TS) and sedentary students (SS) volunteered to 
participate in this study. TS engaged in regular exercise while SS exercised no more than 20 
minutes/week. Metabolic Equivalent of Task (MET) scores for participants were determined. 
Vitamin D intake was assessed using the National Cancer Institute’s 24-hour food recall 
(ASA24). Fasting plasma 25(OH)D levels were quantified via enzyme-linked immunosorbent 
assay.
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Results -  TS reported higher activity levels than SS as assessed with MET-minutes/week and 
ranking of physical activity levels (p<0.05). The reported mean daily intake of vitamin D was 
higher in TS compared to SS (p<0.05) while 25(OH)D plasma levels were lower in TS than in 
SS (p<0.05). In total, 43.8% of the TS were either insufficient (31.3%) or deficient (12.5%) in 
25(OH)D, while none of the SS were insufficient and 13.3% were deficient.
Conclusion -  TS are at increased risk of 25(OH)D insufficiency or deficiency compared to their 
sedentary counterparts residing at the same latitude, despite higher vitamin D intake.
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Introduction
Vitamin D insufficiency and deficiency in adults and children has been described as 
endemic worldwide [1, 2, 3, 4, 5] and investigated extensively in the recent past. One of the 
earliest scientifically identified roles of vitamin D supplementation is regulation of proper 
cellular calcium function in the prevention and treatment of rickets in children and osteomalacia 
in adults [6, 7]. In addition to these roles in mineral balance and bone metabolism, vitamin D has 
pleiotropic effects in many human cells [8]. While consensus has not been reached, recent 
evidence suggests that vitamin D may play a significant role in overall health in addition to bone 
strength and density. Health issues linked to insufficient or deficient levels of vitamin D include 
diabetes [8, 9], cancer [2], thyroid function [10], cardiac volume [11], immune-system function 
[12], obesity [13], cardiovascular disease and metabolic syndrome [8]. Though further research 
is needed, researchers have demonstrated that vitamin D sufficiency is positively correlated to 
proper muscle function [4, 14, 15, 16, 17] and skeletal muscle recovery and regeneration [18] 
while deficiency is associated with muscle pain, weakness [1] and inadequate repair [18].
A rising number of studies suggest that many athletes do not maintain sufficient levels of 
25(OH)D [19] though few studies have investigated this circumstance with relation to 
geographical latitude [20, 21, 22]. The prevailing hypothesis denotes that small sun angles in 
winter months at latitudes greater than 42° result in limited or insubstantial conversion of 7- 
dehydrocholesterol to vitamin D3 in the skin [1, 23, 24]. In a cross-sectional study of 2,548 adults 
in Norway, Larose et al described overall 25(OH)D deficiency (<50 nM) at 40% with a seasonal 
shift of 64% in winter to 20% in summer [3]. Vitamin D levels in populations living at high 
latitudes are more likely to be inadequate as compared to populations living near the equator [25, 
26, 27]. These findings along with those suggesting that athletes are a greater risk of inadequacy
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than non-athletes may prove to compound the overall risk of athletes living and training at high 
latitudes.
Our aim was to test the hypothesis that athletes living in Fairbanks, Alaska, at 64° N are 
at greater risk of vitamin D insufficiency and deficiency as compared to their sedentary 
counterparts living at the same geographic location.
Methods
Approval for this study was secured by the Institutional Review Board of the University 
of Alaska Fairbanks (UAF, #492213-4) prior to data collection. Following an explanation of the 
study, including risks and benefits, we obtained written consent from all participants.
A power analysis using previous studies with athletes was completed prior to recruitment 
of participants. Thirty-one male (n=16) and female (n=15) study participants, all non-pregnant 
and non-diabetic, 18-25 years of age, were recruited from the UAF student-body. They consisted 
of two groups: trained student-athletes (TS, n=16) and sedentary, non-athlete students (SS, 
n=15). All TS participants were members of the UAF cross country skiing and/or cross country 
running teams. TS were engaged in regular endurance exercise for 10 to 20 hours per week for 
at least three months prior to data collection in preparation for National Collegiate Athletic 
Association (NCAA) competitions. SS were recruited through direct contact in entry level 
science classes, fliers posted across the UAF campus, as well as social media. A simple Google 
Forms questionnaire was used to pre-screen SS for current and past exercise habits. SS reported 
not engaging in regular moderate physical activity (defined as “physical activity that takes 
moderate effort and makes you breathe somewhat harder than normal”) for more than 20 minutes 
per bout, one bout per week, over the previous three months.
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Participants completed a questionnaire that included health history, age, sex, and race 
(Table 1.1). There were no significant differences between TS and SS with regards to age or sex. 
Study participants were predominantly white with no significant differences in race between 
groups.
After removal of shoes, socks, and heavy clothing, anthropometric measurements were 
taken by a registered nurse (Table 1.2). Using a TANITA TBF-300A body composition analyzer 
(Tanita Corporation of America Inc., Arlington Hills, Illinois) set to the standard position for all 
participants, weight and percent body fat were measured.
Both groups completed the International Physical Activity Questionnaire (IPAQ) Short 
Form in the presence of a researcher. These data were cleaned and analyzed using IPAQ 
Guidelines for Data Processing and Analysis. Data from one TS and one SS participant were 
excluded based on this analysis. Metabolic Equivalent of Task (MET) scores in minutes/week 
were determined for each participant and classified into one of three physical activity categories: 
walking, moderate, or vigorous.
Vitamin D intake was gleaned from dietary data collected using the ASA24 system. 
Participants were instructed to record food and supplement (vitamin D) intake from one typical 
week day and one typical weekend day. Data were analyzed according to ASA24 protocol.
Blood draws were performed during the last week of November and the first week of 
December. Participants were instructed to fast for 12 hours prior to the blood draw. Consumption 
of water was permitted during the fast. Blood samples were collected in EDTA tubes, placed on 
ice, and centrifuged within two hours of the draw. Plasma was aliquoted and stored at -80° C for 
later analysis.
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A commercially available ELISA kit (Enzo Life Sciences, Farmingdale, New York) was 
used to measure 25(OH)D according to the manufacturer’s instructions. Briefly, 25(OH)D from 
plasma samples and alkaline phosphatase conjugated 25(OH) vitamin D3 bind competitively to 
sheep monoclonal 25(OH)D antibody. The antibody then binds to donkey anti-sheep IgG coated 
on the interior surface of the plate wells. Excess material is washed out, a substrate is added 
causing remaining alkaline phosphatase conjugate to turn yellow, and plate absorbance is read at 
405nm with an optical plate reader. Sample 25(OH)D concentrations were extrapolated from a 
standard curve.
Consensus has not been reached on what constitutes “optimal” levels of serum 25(OH)D 
nor have definitions of sufficiency, insufficiency, or deficiency been standardized. The Institute 
of Medicine (IOM) classification for serum 25(OH)D concentrations was employed for this 
study: >50 nM = sufficient, 30<50 nM = insufficient, and <30 nM = deficient. However, the 
Endocrine Society Guidelines state that a 25(OH)D level of 75 nM is required for sufficiency 
[28]. Ohlund et al [29] cite several reports for their use of the following scale: >75 nM = optimal, 
50<75 nM = suboptimal, 37<50 nM = insufficient, and <37 nM = severely deficient. Though 
limited studies have reported optimal 25(OH)D levels for human athletic performance, it has 
been proposed that higher serum 25(OH)D levels (>100 nM) may improve athletic performance 
[30].
GraphPad Prism version 5.0d (GraphPad Software, Inc., La Jolla, California) was used 
for data analysis. A two-tailed, unpaired t-test was applied to evaluate differences between 
groups in regards to anthropometric data, IPAQ categorical comparisons, overall caloric intake, 
and plasma 25(OH)D concentration. A Mann-Whitney U test was used to assess physical activity 
levels and daily vitamin D intake for TS and SS. Male TS data were also compared to male SS.
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Female TS data were compared to female SS. Differences were considered significant at P<0.05. 
Data are presented as mean ± standard deviation unless indicated otherwise.
Results 
Subject Characteristics
Table 1.1 outlines the demographics of TS and SS. There were no significant differences 
between TS (n=16) and SS (n=15) in age (TS=20.1±2.0, SS=21.5±2.1) or sex (male TS=8, 
female TS=8, male SS=8, female SS=7). All of the TS participants identified their ethnicity as 
white. Of the SS group, fourteen indicated their race as white, one indicated Alaskan Native 
(AN), and two reported as both AN and white.
Analysis of anthropometric data (Table 1.2) revealed significantly lower percent body fat 
and body mass index (BMI) in male TS (10.88±4.02, 21.84±1.69) as compared to male SS 
(19.84±6.15, 26.04±4.14). All members of the TS group had a BMI in the healthy range (18.6­
25.0 kg/m2) while 10 of the SS had a healthy BMI, three were classified overweight (25.1-29.9 
kg/m2) and two were classified obese (>30 kg/m2). Female TS did not show a significant 
difference in percent body fat or BMI compared to female SS. Furthermore, there were no 
significant differences in height, weight, or basal metabolic rate (BMR) between TS and SS for 
either sex.
Physical Activity
Walking, moderate, vigorous, and total MET scores in minutes per week were 
determined for each study participant. IPAQ analysis revealed one TS participant with moderate 
physical activity level while all other participants in the TS group sustained high physical 
activity levels. Conversely, SS participants demonstrated low physical activity levels except for
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three with moderate and two with high levels. However, both MET-minutes/week (U=7.00) and 
categorical ranking of physical activity levels (U=17.5) were found to be significantly different 
between TS (n=15) and SS (n=14) groups. TS and SS groups demonstrated comparable walking 
MET scores (1134.10±578.49, 842.68±1166.34; Figure 1.1). Moderate, vigorous, and total 
METs were significantly greater in the TS group (1864.00±1085.57, 3952.00±2549.41, and 
6910.10±2669.78) compared to the SS group (127.14±200.55, 257.14±778.91, and 
1226.96±1450.22; Figure 1.1).
Vitamin D Intake
Total vitamin D intake for each study participant was analyzed as well as the source: food 
consumption or supplementation (Figure 1.2). Intake of vitamin D from food (Figure 1.2, A) was 
significantly greater in the TS group (316.623±160.79, U=37) than the SS group 
(113.184± 110.13). Of importance, overall caloric intake was significantly higher for TS 
(3022±951.04) as compared to SS (2041±756.23). Male TS (348.00±176.3, U=8) consumed 
significantly more vitamin D from food compared to male SS (72.09±26.88) whereas the intake 
of vitamin D from food in female TS and SS was not significantly different (285.2±148.6, 
160.10±150.40, U=13). It is noteworthy that all participants had vitamin D intake from food 
sources below the Recommended Dietary Allowance (RDA) of 600 IU per day.
Fourteen of 16 (88%) TS reported taking vitamin D supplements on one or both food 
recall days as compared to six of 15 (40%) SS. Vitamin D supplementation (Figure 1.2, B) was 
significantly greater for male TS (1044.00±1445.00, U=10.5) than male SS (146.60±414.70) and 
for sexes combined for TS (820.296±1127.87, U=67.5) than SS (431.533±1091.28). There was 
no significant difference in vitamin D supplementation between TS and SS females 
(596.90±723.6, 757.10±1532.00).
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The total daily vitamin D intake (Figure 1.2, C) was significantly greater for TS 
(1136.92±1205.70, U=50) than SS (546.52±1089.93). Nine (56%) TS and three (20%) SS met or 
exceeded RDA for this age group of 600 IU per day. Total daily IU intake for male TS 
(1391.72±1512.33) was significantly greater than male SS (222.09±430.48) whereas there was 
no significant difference in total intake between female TS and SS (882.10±824.30, 
917.3±1502.00).
Plasma 25(OH)D Levels
Fasting plasma levels of 25(OH)D (Figure 1.3) were significantly lower in the TS group 
(32.24±21.69) than in the SS group (51.92±24.88). TS males (23.91±11.97) demonstrated 
significantly lower levels of 25(OH)D as compared to SS males (56.93±23.14) whereas TS and 
SS females had comparable concentrations (40.56±26.57, 46.20±27.36). Furthermore, 44% of 
the TS participants were either insufficient (31%) or deficient (13%) in 25(OH)D while none of 
the SS were insufficient and 13% were deficient. The remainder of participants in both groups 
exhibited adequate levels.
Discussion
The purpose of this study was to evaluate physical activity, vitamin D intake, and fasting 
plasma 25(OH)D levels in trained student-athletes (TS) compared to sedentary students (SS) 
living in Fairbanks, Alaska, at 64° N. Sampling was conducted in November/December so that 
most, if  not all, of vitamin D in the study population would need to be obtained from diet. Low 
sun angles at this time of year in conjunction with the half life of vitamin D would limit or 
eliminate conversion or storage of vitamin D from sunlight at 64°N. Physical activity was a 
lifestyle factor that was significantly different between the two groups. Most interestingly, TS
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consumed a greater total dietary intake of vitamin D, yet had significantly lower plasma levels of 
25(OH)D as compared to SS. Our hypothesis that TS are at greater risk for 25(OH)D 
insufficiency or deficiency as compared to sedentary counterparts is supported by these data.
Ergocalciferol (vitamin D 2) and vitamin D3 are fat-soluble secosteroid compounds that 
are essential to human health. D 2 is synthesized by plants and fungi and may serve as a dietary 
source for humans [10]. D3 is produced by conversion of 7-dehydrocholesterol in the skin via 
UV radiation. This transformation provides the most readily available source of D 3 for human 
metabolism [29]. Vitamins D2 and D3 are inactive molecules that undergo two hydroxylation 
reactions for activation. In a step-wise fashion, D2 and D3 are converted to 25(OH)D in the liver 
before forming calcitriol (1,25(OH)2D) in the kidney. Concentrations of 1,25(OH)2D in serum 
are tightly regulated by parathyroid hormone, calcium, and phosphate [31], with a circulating 
half-life of approximately 15 hours [32]. In contrast, 25(OH)D has a variable half-life of 15-45 
days [33] making it a better indicator of vitamin D status and the standard measurement for 
research and clinical trials.
D 3 may also be ingested, though few unfortified foodstuffs provide sufficient 
concentrations to support adequate human health. Unfortified foods which are the exception 
include oily fish such as salmon, mackerel, herring, and cod liver oil [23]. Oily fish are thought 
to have been an important source of vitamin D for indigenous peoples of the circumpolar north. 
In fact, shifts away from traditional subsistence diets towards more westernized diets are likely 
lending to increasing prevalence of vitamin D deficiency and insufficiency in Alaska Natives 
[34]. Participants in this study were of predominantly European decent, did not live on a 
subsistence diet, nor did they consume higher than normal intake of oily fish.
Vitamin D insufficiency and deficiency has been identified as a worldwide health
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problem [23]. In a meta-analysis of 394 studies with over 33,000 subjects worldwide, Hagenau et 
al [35] found mean 25(OH)D concentrations of 53.9±1.0 nM which is considered suboptimal or 
borderline insufficient. Furthermore, elite and sub-elite level athletes appear to be at higher risk 
of vitamin D deficiency than others [14]. Explanation as to why athletes may be at higher risk of 
deficiency include the utilization of 1,25(OH)2D in muscle recovery [36], increased use of indoor 
training facilities [14], and increased use of sunblock and restrictive uniforms [28]. Moreover, it 
has been reported that exposure to winter sunlight at latitudes greater than 52° does not promote 
vitamin D 3 synthesis in human skin from October through March [24] and that those living at 
latitudes higher than 42° are at increased risk for seasonal insufficiencies or deficiencies in 
25(OH)D [37].
Few studies, however, investigated vitamin D status in outdoor athletes living at high 
latitudes. Most recently a large study over four years evaluated vitamin D status according to 
sun exposure and oral supplementation in Polish athletes training outdoors. As expected, athletes 
experienced the most severe hypovitaminosis in winter months. Interestingly, increased winter 
sun exposure in athletes from northern climes -  made possible by travelling to locations closer to 
the equator -  improved vitamin D status more than oral supplementation [20]. Two studies that 
are more similar in scale and design to this one reported exacerbated hypovitaminosis in both 
soccer players training at 53°N [22] and rugby players training at 44°N [21] in the winter 
months. Hypovitaminosis was present, albeit to a lesser degree, in summer months indicating 
that higher muscle mass of athletes require larger amounts of vitamin D [21]. Hence, athletes 
living and training in the subarctic are likely to be at even greater risk than the general 
population as well as athletes living and training at lower latitudes.
In this study, TS consumed a greater quantity of vitamin D via food sources than SS
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which may be a result of food choices and/or significantly greater daily caloric intake (kcal) 
(3022.67±951.04) compared to the SS group (2040±756.32). Additionally, supplemental vitamin 
D intake was greater in TS than SS in both numbers of individuals taking vitamin D as well as 
the amount taken. Despite the higher intake, TS demonstrated significantly lower levels of 
plasma 25(OH)D compared to SS. Furthermore, nearly half of TS had insufficient or deficient 
levels of 25(OH)D while none of the SS were insufficient and only two were deficient.
These data demonstrate that male TS have significantly lower 25(OH)D levels than male 
SS; females showed no difference between groups. We speculate that this discrepancy between 
sexes was a result of significant differences in body composition seen in the males but not the 
females. Research on body composition and vitamin D status indicate that both adiposity and 
reduced mean muscle mass contribute to vitamin D deficiency. For instance obesity has long 
been associated with low 25(OH)D status [6], despite previous animal studies that establish 
adipose tissue as the major storage site for D3 [38]. Epidemiological studies have demonstrated 
lower vitamin D levels associated with higher BMI [39, 40]. Our data contrast these findings; 
however, any conclusion based on body fat would be difficult in the current study given that only 
five of the study subjects were classified as overweight or obese. Research by Ko et al found that 
men with a lower appendicular skeletal muscle mass index (ASMMI) score were more likely to 
be vitamin D deficient [41]. The authors conclude that a positive relationship between 25(OH)D 
and muscle mass in men may exist. Our results are also in conflict with these findings because 
we would expect our TS males to have higher muscle mass than their sedentary counterparts.
The BMI of well-trained athletes is influenced primarily by their body fat content as they tend to 
display optimal muscle mass [42]. It is important to note however that ASMII and percent body
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fat are not identical measurements. A larger sample size would provide clarity on the relationship 
between hypovitaminosis, muscle mass, and body fat composition.
Notwithstanding the small sample size, we showed significantly lower vitamin D levels 
in trained athletes living at high latitudes compared to their sedentary counterparts despite higher 
vitamin D intake. Our data suggest that this risk is more pronounced in males than in females. 
This study lends to the small, but growing body of evidence that athletes living at high latitudes 
are at an even greater risk of vitamin D insufficiency or deficiency than other individuals living 
at the same latitude. Further investigations are needed to determine if lower levels of plasma 
25(OH)D in TS are due to an enhanced rate of skeletal muscle repair and/or other mechanisms 
unique to endurance athletics. These findings suggest that athletes living at high latitudes would 
benefit from regular vitamin D screening and oral supplementation.
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Table 1.1: Demographic data for trained athlete students and
sedentary students living at 64°N.
Parameter Trained Sedentary
n 16 15
AgeM 20.1 ± 2.0 21.5 ± 2.1
Gender
Male 8 8
Female 8 7
Race
White 16 14
Black 0 0
Alaskan Native 0 3b
Asian 0 0
Demographic data as reported on health history form. MData 
reported as mean ± standard deviation. No significant 
differences between groups for age or gender. ^Two 
participants of the sedentary group identified as both White 
and Alaskan Native ethnicity.
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Table 1.2: Anthropometric data for trained athlete students and sedentary students
living at 64°N.
Measurement Trained
Mean
Sedentary
MeanF
P value
Height (cm)
Male 179.0 ± 7.47 177.93 ± 6.73 0.7591
Female 166.2 ± 6.02 161.8 ± 9.78 0.3131
W eight (kg)
Male 70.13 ± 9.24 82.96 ± 14.4 0.0512
Female 59.74 ± 7.06 61.42 ± 18.65 0.8126
Body Fat %
Male* 10.88 ± 4.02 19.84 ± 6.15 0.0039
Female 23.45 ± 5.59 25.30 ± 11.06 0.6832
Body Mass Index (kg/m 2)
Male* 21.84 ± 1.69 26.04 ± 4.14 0.0188
Female 21.65 ± 2.04 23.44 ± 6.47 0.4686
Combined* 21.74 ± 1.81 24.83 ± 5.32 0.0368
Basal Metabolic Rate (kcal/day)
Male 1787 ± 153.4 1956 ± 218.0 0.0943
Female 1445 ± 77.27 1446 ± 190.7 0.9950
Data reported as means ± SD. *significantly different (p< 0.05). FFemale
participants in this group n=7, all other groups n=8.
31
Figure 1.1: Physical activity (walking, moderate, vigorous, and total) reported in MET- 
minutes/week for trained student athletes (open bars) and sedentary students (solid bars). 
Analysis was conducted according to International Physical Activity Questionnaire guidelines 
for data processing. Each bar represents the group mean ± SEM. *p<0.05.
Figure 1.2: Vitamin D (IU) from (A) food, (B) supplementation, and (C) total intake in trained 
student athletes (open bars) and sedentary students (solid bars). Data reported for males, females, 
and sexes combined. Data were obtained via the National Cancer Institute’s Automated Self­
Administered 24-hour Recall system. Each bar represents the group mean ± SEM. *p<0.05.
Figure 1.3: Fasting plasma 25(OH)D levels in trained student athletes (open bar) and sedentary 
students (solid bar). Data reported for males, females, and sexes combined. 25(OH)D levels were 
quantified by ELISA. Each bar represents the group mean ± SEM. *p<0.05.
Figure Captions
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Chapter 2: Seasonal changes of vitamin D and cognitive function in collegiate cross
1 2country skiers at 64° north ’
Abstract
PURPOSE: Vitamin D deficiency is well-documented in populations living above 37° N and 
more pronounced during winter months. Athletes are more susceptible to deficiency than non­
athletes. Vitamin D has been linked to cognitive processes. Winter-sports athletes residing in 
the circumpolar North may exhibit vitamin D deficiency and depressed cognitive abilities during 
the competition season. This study aimed to determine if there are significant differences in 
vitamin D and cognitive function in winter athletes during mid-competition season versus post­
season in the circumpolar North.
METHODS: Fifteen competitive cross country skiers residing at 64° N volunteered for this 
study. Blood samples were taken in early February (“mid-season”) and late April (“post­
season”). Subjects completed the Purdue Pegboard Test (PPT), an assessment of cognitive 
function, at the time of the blood draws. Plasma 25-hydroxyvitamin D [25(OH)D)]
1 1 1 2  3 3 1 2Scott P. Jerome , Kriya L. Dunlap , , Hannah T. Short , Rebecca L. Gever , Lawrence K. Duffy , , Andres D.
Dajles4, and Arleigh J. Reynolds5
departm en t of Chemistry & Biochemistry, University of Alaska Fairbanks, Fairbanks, AK, 99775, USA
2Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks, AK, 99775, USA
departm en t of Biology & Wildlife, University of Alaska Fairbanks, Fairbanks, AK, 99775, USA
4Biomedical Learning & Student Training Program, University of Alaska Fairbanks, Fairbanks, AK, 99775, USA 
departm en t of Veterinary Medicine, University of Alaska Fairbanks, Fairbanks, AK, 99775, USA
2 Prepared for submission, Medicine & Science in Sports & Exercise
37
concentration was measured as using an ELISA. Significance was determined by Wilcoxon and 
Mann-Whitney tests.
RESULTS: Subjects exhibited significantly lower (p<0.05) mean concentration of plasma 
25(OH)D in post-season (8.45 nM ± 2.92 SEM) as compared to mid-season (14.81 ± 2.17). 
Mean PPT scores were significantly higher in post-season than mid-season (dominant hand, 
p<0.05; non-dominant hand, p<0.01; assembly, p<0.001; both hands p<0.0001) during post-season 
recovery.
CONCLUSION: Post-season 25(OH)D concentration was significantly lower than mid-season. 
PPT scores improved significantly in all four batteries in the post-season; 25(OH)D may not 
necessarily be linked to cognitive function measured with PPT. Mean 25(OH)D from both mid- 
and post-season fell below the Institute of Medicine’s definition of “deficient” suggesting that 
subjects’ improvement on PPT may have been attributable to another factor(s) such as reduced 
stress levels.
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Introduction
Vitamin D insufficiency and deficiency are endemic worldwide [1, 2, 3]. Over the past 
30 years vitamin D has been widely investigated with a sharp uptick in published work since 
2003. One of the most studied and earliest understood roles of vitamin D is its regulation of 
mineral balance in bone metabolism. Researchers in the early 20th century began to understand 
that vitamin D supplementation could be used for the prevention and treatment of rickets in 
children and osteomalacia in adults [4, 5]. While this classical role of vitamin D is the most 
observable and best understood, vitamin D also has pleiotropic effects in a variety of human cell 
types [6]. Vitamin D insufficiency or deficiency has been linked with diabetes [6], cancer [1], 
thyroid dysfunction [7], low cardiac volume [8], impaired immune-system function [9], obesity 
[10], reduced cognitive function [11], metabolic syndrome, and cardiovascular disease [6].
While not conclusive, researchers have demonstrated that vitamin D sufficiency is positively 
correlated to proper muscle function [12, 13] and skeletal muscle repair and recovery [14]. 
Furthermore, muscle pain, weakness, and inadequate repair have been associated with vitamin D 
deficiency [14]. Clearly vitamin D ’s effects extend beyond bone health.
Though not uniformly accepted [15], recent studies suggest that some athletes do not 
maintain sufficient levels of 25-hydroxyvitamin D [25(OH)D] [16]. In a meta-analysis of 23 
studies including 2,313 athletes, Farrokhyar et al. found that 56% displayed inadequate plasma 
vitamin D levels (<80 nM) [17]. While the Farrokhar study did find that inadequacy varied 
significantly with geographical location, few other studies have investigated this circumstance 
with relation to latitude [18]. For the North, the predominant hypothesis asserts that small sun 
angles in winter months at latitudes greater than 42° N result either in limited, severely limited, 
or insignificant conversion of 7-dehydrocholesterol by keratinocytes in the skin to vitamin D3
39
[19, 20]. A cross-sectional study of 2,548 adults in Norway, revealed that 64% of participants 
were vitamin D deficient in winter (<50 nM) and 20% in summer. The researchers reported an 
overall rate of deficiency at 40% [2]. A greater risk of vitamin D deficiency exists in populations 
living at high latitudes as compared to populations living closer to the equator [21, 22, 23]. In a 
previous study our team found that trained cross country skiers living at 64° north had lower 
circulating vitamin D than their sedentary counterparts despite greater intake through diet and 
supplementation [24]. These studies, in addition to those proposing that athletes are at greater 
risk of deficiency than non-athletes, suggest that the overall risk for athletes living and training at 
high latitudes may be increased.
Vitamin D receptor (VDR) and the enzyme responsible for hydroxylating vitamin D to its 
active form, 1 alpha-hydroxylase, have been identified in human brain tissue [25]. A positive 
correlation between cognitive function and 25(OH)D concentration has been demonstrated in 
numerous studies. Vitamin D deficiency and insufficiency are directly correlated with 
performance on cognitive tests [26]. This was especially prevalent in finger tapping and hand 
movement tests similar to the Purdue Pegboard Test [27].
This study had two primary goals: first, to determine if differences in vitamin D levels 
and cognitive function exist in trained endurance athletes between the middle of the competition 
season and during the post-season recovery phase; and second, to compare cognitive function 
test scores with the 25(OH)D levels of individual participants who reported a drop in their 
athletic performance during the season.
We hypothesize that 25(OH)D levels will be significantly higher in trained endurance 
athletes after one month of recovery from the competition season than during mid-season. Also, 
subjects will score significantly lower on cognitive function tests during the mid-season than
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during recovery, and that subjects who experience a decrease in athletic performance during the 
season will have lower mean cognitive function scores.
Methods
The University of Alaska Fairbanks (UAF) Institutional Review Board approved this 
study (#838437-5) prior to data collection. Also prior to data collection, written consent of all 
participants was obtained after explanation of the study, including risks and benefits. A 
presentation by the researchers was given to members of the UAF cross country ski team; 
attendance was optional. The presentation outlined current research questions, the specific 
purpose of this project, opportunities to volunteer for the project as study participants, potential 
risks of participation, and anticipated benefits of participation. Fifteen members of the ski team 
volunteered to participate (Table 2.1). A power analysis of exercise science studies utilizing 
human athletes was completed prior to participant recruitment. Our analysis suggested that a 
group of 12 would be sufficient for determining significant differences in vitamin D parameters. 
All participants were preparing for, and competing in, National Collegiate Athletic Association 
(NCAA) cross country skiing competitions. Participants completed the International Physical 
Activity Questionnaire (IPAQ) to assess overall activity level through metabolic equivalent task 
(MET) minutes; all participants were rated as meeting “health enhancing physical activity” 
according to IPAQ guidelines.
Participants completed questionnaires, had blood drawn, and completed a simple test of 
cognitive function at two different times during their athletic calendar: early February (“mid­
season”) and late April (“post-season recovery”). The February sampling occurred at the 
approximate midpoint of the competitive ski season. The April sampling took place after
41
approximately one month of recovery following the conclusion of the season. Participants were 
asked to fast for 8-10 hours prior to each testing date/time and to refrain from exhaustive 
physical activity during that time period. Consumption of water was allowed during the fasts. 
Questionnaires were administered by a trained researcher prior to anthropometric measurements 
and blood draws. The first questionnaire surveyed the participants regarding athletic 
performance, unexplained drops in athletic performance, activity levels, and vitamin D 
supplementation. The IPAQ Short Form surveyed the participants in greater depth about 
physical activity levels.
Following the completion of questionnaires and prior to blood draws a trained medical 
student measured height, weight, and body composition using a TANITA TBF-300A body 
composition analyzer (Tanita Corporation of America Inc., Arlington Hills, Illinois) set to the 
standard position for all participants. Blood draws were performed by a registered nurse trained 
in phlebotomy. Blood samples were collected in three tubes: 3.5 mL serum separation, 4 mL 
EDTA, and 10 mL EDTA. Through the UAF Student Health and Counseling Center the 3.5 and 
4 mL tubes were sent to an outside lab for processing (Quest Diagnostics, Secaucus, New 
Jersey). The 10 mL tubes were placed on ice and centrifuged within 30 minutes of the draw. 
Plasma was aliquoted immediately, flash frozen, and stored at -80° C for later analysis.
Following the blood draw, participants performed the Purdue Pegboard Test (Lafayette 
Instrument, Lafayette, Indiana) under the supervision of a trained researcher. The Purdue 
Pegboard Test (PPT) is a simple test of neuropsychological skills and cognitive function [28]. 
Participants completed four separate timed tasks. The first three -- dominant hand, non­
dominant hand, and both hands simultaneously -  required the participant to place small, metal 
pegs in holes. The final test required the assembly of a small pieces of hardware using metal
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pegs, washers and collars with both hands. Each task was performed three times with the mean 
of each serving as the final score.
To measure 25(OH)D, a competitive, enzyme-linked, immunosorbent assay (ELISA) kit 
(Enzo Life Sciences, Farmingdale, New York) was used according to the manufacturer’s 
instructions. Plasma 25(OH)D from samples and alkaline phosphatase conjugated 25(OH) 
vitamin D3 compete to bind to sheep monoclonal 25(OH)D antibody. The bound antibody then 
binds to donkey anti-sheep IgG that is coated on the interior surface of the plate wells. Excess 
material is washed from each well, a substrate is added causing remaining alkaline phosphatase 
conjugate to turn yellow, and well-color is read at 405nm with an optical plate reader (Synergy 
HT, BioTek Instruments, Winooski, Vermont). Sample 25(OH)D concentrations are then 
extrapolated from a standard curve.
Statistical analysis was performed with Prism (versions 5, 6 &7, Graphpad Software,
Inc.). D ’Agostino & Pearson omnibus test was used to determine normality of data sets. If 
normal distribution was found, data were compared with a paired t-test. If data were not 
normally distributed it was compared with the Wilcoxon matched-pairs signed rank test. 
Unpaired data sets were analyzed with the Mann-Whitney test. Correlations were determined 
with Spearman’s rank correlation coefficient. Significant differences are reported at P < 0.05.
All error is reported as standard error of the mean (± SEM).
Results
Participants reported significantly lower weekly mean MET minutes in post-season recovery 
(3185 ± 446.1) as compared to mid-season (5336 ± 427.4). There were no significant differences 
in percent body fat for all participants, males, or females between mid-season and post-season
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recovery (Table 2.1). Mean plasma 25(OH)D concentration was significantly lower (P = 0.0084) 
in post-season recovery (8.45 ± 2.92 nM) than mid-season (14.82 ± 2.17 nM) (Figure 2.1).
When analyzed according to sex, we found that the male group displayed significantly lower 
plasma 25(OH)D concentration in post-season recovery (4.32 ± 1.30 nM) than mid-season 
(15.48 ± 3.08 nM) while the female group revealed no significant difference between post­
season recovery (13.18 ± 5.79 nM) and mid-season (14.08 ± 3.27 nM) (Table 2.2). There was no 
significant difference in mean 25(OH)D between males and females in the mid-season nor in 
post-season recovery.
Participants scored significantly higher in all four PPT batteries in post-season recovery 
than mid-season (Figure 2.2). We found a significant, positive correlation between plasma 
25(OH)D concentration and the PPT assembly battery (P = 0.049) in post-season recovery. 
However, we found no other significant correlations between 25(OH)D and PPT batteries in 
either post-season recovery or mid-season. There was no correlation between percent body fat 
and 25(OH)D.
Six participants reported experiencing at least one drop in athletic performance lasting three 
weeks or longer during the ski season. Mean 25(OH)D for these six (6D) was significantly 
lower post-season (4.20 ± 1.81 nM) than mid-season (14.05 ± 3.85). Mean 25(OH)D 
concentrations of the nine participants (9ND) who reported no drop(s) in performance lasting 
three weeks or longer at any time during the season displayed no significant difference between 
post-season (11.28 ± 4.58) and mid-season (15.34 ± 2.50) (Figure 2.3).
Among 6D and 9ND independently, we investigated correlations between plasma 
25(OH)D concentration and PPT. Of the 16 possible combinations, only one displayed a
44
significant correlation. In the post-season condition, 6D displayed a positive correlation between 
plasma 25(OH)D concentration and assembly battery performance.
For the total group, supplementation taken during the season was generally stopped in the 
post-season recovery. Reported weekly mean vitamin D intake from oral supplementation was 
significantly lower in post-season recovery (2,333 ± 1876 UIs) versus mid-season (11,327 ± 
3688). Three of the 15 participants reported taking a vitamin D supplement during post-season 
recovery; 11 reported taking a supplement during the mid-season. Of 6D, two reported 
supplementation in post-season recovery and five in mid-season. In the 9ND group, one reported 
supplementation in post-season recovery and six in mid-season.
Discussion
There is little consensus within the exercise science community regarding what 
constitutes “optimal” levels of 25(OH)D for athletic performance [29, 30]. At the lower end of 
the scale, what defines a “sufficient” level of vitamin D for basic human health also remains 
controversial [31, 32]. The Endocrine Society guidelines state that plasma 25(OH)D 
concentration of 75 nM is required for sufficiency [33]. Ohlund, Silfverdal, Hernell, & Lind cite 
several reports for their use of the following scale: >75 nM = optimal, 50>75 nM = suboptimal, 
37>50 nM = insufficient, and <37 nM = severely deficient [29]. For the purpose of this study we 
used a conservative scale from the Institute of Medicine (IOM) to classify plasma 25(OH)D 
concentrations: >50 nM = sufficient, 30>50 nM = insufficient, and <30 nM = deficient. The 
mean of all participants displayed vitamin D deficiency in both the mid-season (13.94 ± 2.41 
nM) and post-season recovery (8.45 ± 2.92 nM). As reported, the post-season recovery mean 
value was significantly lower than mid-season. This data refute our hypothesis that mean
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25(OH)D level would be significantly higher in post-season recovery. This may be attributable 
to the fact that only four of the 11 participants who reported taking a vitamin D supplement in 
the mid-season continued to take a supplement in post-season recovery. Weekly mean vitamin D 
intake from supplements, inclusive of all participants, dropped from 11,327 IUs to 2,333. Both 
the IOM and the United States Department of Agriculture recommend a daily allowance of 600 
IUs (4,200/wk). The participants’ post-season recovery mean supplementation falls far below 
these recommendations. Though we did not assess participants’ vitamin D intake through diet, 
our data add to the evidence that people living in the far North are unable to produce virtually 
any vitamin D in the skin via UV radiation in early spring due to low sun angles [34]. Therefore, 
vitamin D supplementation and/or a diet plentiful with foods rich in vitamin D -  fortified and/or 
naturally occurring -  is required to achieve recommended plasma 25(OH)D concentration.
One proposed pleiotropic effect of vitamin D is muscle trophicity. Specific populations 
experience increased demand of vitamin D from muscle damage, atrophy, or loss, such as 
athletes or the elderly. They may require higher production and/or intake of vitamin D in order 
to maintain or increase muscle mass [35]. Our data suggest that participants on average were 
vitamin D deficient within a period of high exercise exertion (mid-season) as well as during a 
recovery phase (post-season). Muscle function nor lean body mass was tested for. A follow-up 
study encompassing an entire training/competition cycle (year) with quarterly sampling and 
testing to include muscle force production, exercise time to exhaustion, and total body 
composition will determine if a correlation exists between vitamin D and muscle function and 
mass in northern athletes.
The significant decrease from mid-season to post-season recovery in plasma 25(OH)D 
concentration was at least partially driven by the male participants. The female participants
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showed no significant difference in 25(OH)D between mid-season and post-season recovery, 
while the males displayed a significant reduction of over 66%. Despite the significant difference 
in mean 25(OH)D in males from mid-season to post-season recovery, there were no significant 
differences between male and female 25(OH)D in either the mid-season or post-season 
conditions. In the mid-season, 11 (5 = M, 6 = F) of 15 (8 = M, 7 = F) participants reported 
taking a vitamin D supplement; in post-season recovery only three participants (1 = M, 2 = F) 
reported doing so. Therefore, it is unlikely that supplementation explains the difference in 
plasma 25(OH)D between the sexes. Further research with a more robust sample size is 
warranted to investigate if correlations exist between sex, adiposity, and vitamin D status among 
northern athletes. In the lower populated Arctic and sub-Arctic, cross-regional groups would be 
needed to generate a sufficient number of subjects. However, this would introduce more 
heterogeneity in environmental factors.
The Purdue Pegboard Test was employed in order to measure cognitive function.
Vitamin D insufficiency and deficiency have been linked to decreased cognitive function, though 
primarily in the elderly [27]. Our findings indicate that while plasma 25(OH)D concentration 
dropped significantly from mid-season to post-season recovery, PPT scores rose significantly 
from mid-season to post-season recovery. This contradicts our hypothesis, though the scope is 
limited. The method used, specifically the dates of testing, did not permit testing participants 
when plasma 25(OH)D concentrations would likely be the highest (late summer). The current 
study revealed that all participants were vitamin D deficient at the time of both PPT tests. 
Interestingly, we found significant, positive correlations between 25(OH)D and the assembly 
battery for all participants in post-season recovery and for 6D in the post-season recovery. The 
assembly battery, requiring the use of both hands to build a small component from four small
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metal pieces, is the most complex battery of the PPT. Though far from conclusive, these 
correlations do support a hypothesis that vitamin D levels and cognitive function in athletes are 
positively linked. The overall rise in PPT scores may be explained by another factor altogether. 
Total stress and cumulative fatigue experienced by the participants may have been substantially 
lower in April than in February. The competition season is characterized by multiple 
intercollegiate ski competitions, multiple trans-continental flights, darkness, and extremely cold 
temperatures. The alleviation of some stressors -  conclusion of competition, end of athletic 
travel, increased daylight, moderating temperatures -  may explain higher PPT scores in post­
season recovery [36, 37]. Repeating the PPT and 25(OH)D screening with polar region athletes 
and controls monthly during the year may help to reveal if  a link between mental processes and 
vitamin D exists within this population.
Improvement in exercise performance is based on the simple principle of overload and 
recovery [38]. If  a body is stressed with a workload that is greater than what is normally 
experienced and then is allowed to recover, a “supercompensation” effect occurs. The body 
reacts to the stress of the higher workload by becoming stronger and a new level of fitness is thus 
attained [38]. This normal overload and recovery process is termed “functional overreaching” 
(FO). However, when the workload is set too high or, more likely, when the recovery period is 
inadequate, athletic performance can stagnate, a condition known as “non-functional 
overreaching” (NFO). Functional overreaching and NFO exist on a spectrum with a third 
possible outcome called “overtraining” (OT). Overtraining is characterized primarily by an 
unexplainable, sustained drop in athletic performance despite seemingly normal training cycles 
[39]. If the workload in OT is too great and/or the recovery is not sufficient and performance 
drops. Overtraining syndrome (OTS) is a maladaptation to training causing a long term decline
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in athletic performance. Recovery may require weeks, months, or years, while some never 
completely recover or reach pre-OTS performance [40]. OTS has several symptoms, but the 
drop in athletic performance is often the most pronounced. It is proposed that athletic training is 
not the only contributing factor to OTS [39]. While there is no test for OTS, it can be diagnosed 
by a healthcare professional following a thorough review of the athlete’s training/competition 
history and diet history, and by ruling out all other possible causes for the decline in performance 
[39]. Other causes for decreasing performance, which may eliminate the OTS diagnosis, 
include, but are not limited to, bacterial infection, viral infection, anemia, and negative caloric 
balance [40]. An athlete may still be diagnosed with OTS if any of the aforementioned 
conditions occurred as a result of OTS. While subjective, one possible marker of NFO or OT is 
an unexplainable drop in athletic performance lasting three weeks or longer [40]. Our study 
identified six individuals who reported at least one drop in performance lasting at least three 
weeks during the competition season.
There were no significant differences in mean 25(OH)D concentrations between 6D and 
9ND in the post-season recovery nor mid-season conditions. When examining 6D independently 
we found mean 25(OH)D significantly lower in post-season recovery than mid-season. This 
decline in vitamin D was not mirrored in 9ND (Figure 2.3). Mean plasma 25(OH)D 
concentrations for 9ND showed no significant difference between mid-season and post-season 
recovery. We found that without 6D there would be no significant difference in mean plasma 
25(OH)D concentration from mid-season to post-season recovery indicating that vitamin D may 
play a role in athletic performance. In addition to the influence of male participants, it is clear 
that all who reported a drop in athletic performance helped to drive mean 25(OH)D
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concentration downward in the post-season condition. The 6D group is split evenly by sex, three 
female and three male.
This study examined plasma 25(OH)D concentrations, PPT scores, and athletic 
performance during the mid-season and post-season recovery in trained cross country skiers 
living in Fairbanks, Alaska, at 64° N. It revealed that study participants were vitamin D deficient 
in both testing conditions and vitamin D was significantly lower in the post-season recovery. 
Male participants and all who reported a drop in performance were largely responsible for the 
decline in plasma 25(OH)D concentration. A reduction in vitamin D supplementation may 
account for part of the change in plasma 25(OH)D concentration. Due to low sun angles, 
vitamin D cannot be synthesized in the skin via UV radiation from October through March at 64° 
N [34]. Scores on the PPT were significantly higher in post-season recovery. A reduction in 
athletic and environmental stressors and fatigue may account for part of the change in PPT 
scores. We discovered positive correlations between the assembly battery of the PPT and mean 
plasma 25(OH)D concentrations in the post-season condition for the entire group as well as those 
who reported a drop in athletic performance. Athletes who reported a drop in performance 
showed significantly lower mean plasma 25(OH)D concentration in post-season recovery. Our 
results suggest that athletes are important research subjects for understanding the relationship 
between plasma 25(OH)D concentration and human health in stressful environments like the 
circumpolar North.
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Table 2.1
N Age
Body fat (%) Total METf (min/wk)
Mid-season Post-season Mid-season Post-season
Total 15 20.4 ± 1.64 NA NA
5335 
± 427
3185** 
± 446
Male 8 20.6 ± 1.92
12.0 
± 0.387
11.9 
± 0.573
4903 
± 449
3447 
± 735
Female 7 20.1 ± 1.35
29.4 
± 2.22
28.7 
± 2.29
5830 
± 754
2886* 
± 495
Age, percent body fat, and MET minutes/week for all participants, males, and females. Mean 
values ± SEM. ^Metabolic Equivalent Task. **p<0.01 *p<0.05
Table 2.2: Vitamin D concentration
Mid-season Post-season
Total 14.81 ± 2.17 8.45 ± 2.92 *
Male 15.48 ± 2.25 4.31 ± 0.95 *
Female 14.08 ± 3.27 13.18 ± 3.95
Plasma 25(OH)D concentration (nM) of the entire group (N = 15), males (8), and females 
(7) in the mid-season and post-season recovery. Mean values ± SEM. p<0.05.
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Figure 2.1. Mean plasma 25(OH)D concentration of 15 trained cross country skiers in the middle of 
the competition season ("mid-season") and following one-month recovery (post-season").
Figure 2.2. Purdue Pegboard Test results by individual battery during mid-season and post-season 
recovery, reported with mean values ± SEM. All values were significantly higher during post-season 
recovery. A. Dominant 17.04 ± 0.4689, 18.00 ± 0.3381; B. non-dominant 15.98 ± 0.4173, 16.89 ± 
0.2889; C. both hands 12.98 ± 0.2591, 14.02 ± 0.2882; D. assembly 41.69 ± 1.128, 46.64 ± 0.8875.
Figure 2.3. Mean plasma 25(OH)D concentration during mid-season and post-season recovery of: A. 
athletes reporting at least one drop in performance lasting three weeks or longer during the 
competitive season; and B. athletes reporting no drop(s) in performance lasting three weeks or longer 
during the competitive season.
Figure Captions
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1 2Chapter 3: Oxidative stress in collegiate cross country skiers in mid- and post-seasons ’ 
Abstract
Purpose: The oxidative stress (OS) hypothesis of overtraining syndrome argues that increased 
production of free radicals through exercise cause muscle fatigue and damage resulting in lower 
athletic performance. Several studies have investigated OS immediately before and after 
exercise bouts in a training macrocycle. Out study aimed to compare OS of endurance athletes 
between a competition macrocycle and the immediate post-season recovery macrocycle. In 
addition, we aimed to identify athletes who experienced an unexplainable drop in athletic 
performance during the competition season in order to compare their OS to those who 
experienced no drop in performance.
Methods: Fifteen members of the University of Alaska Fairbanks cross country ski team 
volunteered for this study. Blood samples were taken in early February (“mid-season”) and late 
April (“post-season”). Participants completed questionnaires regarding physical activity and 
athletic performance at the time of the blood draws. Plasma was analyzed for 4-hydroxynonenal
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(HNE), nitrotyrosine, nitric oxide (NOX), and superoxide dismutase (SOD). Significance was 
determined by Wilcoxon and Mann-Whitney tests.
Results: Participants displayed significantly higher (p<0.05) SOD activity in the post-season 
(0.02065 U/mL ± 0.006477 SEM) as compared to mid-season (0.04459 U/mL ± 0.005860). Six 
athletes reported an unexplainable drop in performance (6D). In the post-season, HNE 
concentration was significantly higher (p<0.05) for 6D (197.5 pg/mL ± 22.79) than for 
participants who did not report such a drop (69.80 pg/mL ± 33.59). 6D SOD activity was 
significantly higher in post-season (0.05048 U/mL ± 0.004688) than mid-season (0.01241 U/mL 
± 0.006469).
Conclusion: Signs of oxidative stress and mitigation during the post-season recovery 
macrocycle were higher in athletes who reported experiencing a drop in athletic performance 
during the competition season macrocycle.
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Introduction
Of all the diseases, injuries, and illnesses which can negatively affect performance of 
elite (world class) and sub-elite (collegiate, national, and regional level) endurance athletes, few 
are more frustrating for athletes, coaches, and physicians than overtraining syndrome (OTS). 
Characterized by an unexplainable drop in athletic performance, OTS symptoms can also include 
general malaise, lethargy, disrupted cognitive function, mood swings, depression, and sleep 
disorders [1]. Meeusen et al. describe OTS as a “prolonged maladaptation” of biological, 
neurochemical, and hormonal regulation systems [2]. The diagnosis of OTS may result when no 
other explanation for an athlete’s prolonged drop in performance can be identified [1]. A recent 
search of the PubMed database produced 150 references for “overtraining syndrome”, 73 for 
“overtraining syndrome diagnosis”, and only two for “overtraining syndrome prediction”. A 
2012 Joint Consensus Statement on OTS from the European College of Sport Science and the 
American College of Sports Medicine identified no convincing evidence as to the causes of the 
condition [2]. To date, most published studies regarding OTS have focused on prevention, 
symptoms, diagnoses, and recovery [1, 2, 3, 4, 5, 6, 7]. A gap in the literature exists with regards 
to prediction. The basic question, “Who is most susceptible to developing OTS?” remains 
unanswered.
Several hypotheses exist regarding the etiology of OTS, ranging from chronic glycogen 
depletion to inflammatory cytokine release [1]. The oxidative stress hypothesis asserts that when 
oxidative stress becomes pathologic inflammation, muscle fatigue and soreness will result in 
reduced athletic performance [1]. Tanskanen, Atalay, & Uusitalo found indicators of higher 
oxidative stress in overtrained athletes than in controls both at rest and during exhaustive 
exercise, suggesting that oxidative stress plays a role in the pathophysiology of OTS [8]. A
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study featuring a periodized training protocol for human participants culminated with an 
overtraining (OT) block resulting in significant increases in three oxidative stress markers 
(OSMs): isoprostanes, thiobarbituric acid-reactive substances, and protein carbonyls [9]. While 
studies have revealed a link between OSMs and OTS following acute exercise [8, 9], few if any 
have examined the relationship between oxidative stress and overtraining over a training or 
competition macro cycle.
Functional overreaching (FO) is defined as the normal overload, recovery, and super­
compensation cycle required for athletic improvement. Nonfunctional overreaching (NFO) 
shares an overload feature with FO, but an ineffectual recovery period leads to stagnant 
performance. OT shares an overload period and ineffectual recovery with NFO. However, 
instead of a performance plateau, performance drops with OT [2]. These three outcomes to 
athletic training -  FO, NFO, and OT -  are not completely isolated responses but exist together on 
a stress/response continuum. This study examines the response to a macro training cycle by 
examining athletes’ abilities to adapt to stress and reach homeostasis. While it is unclear if  any 
of our participants were overtrained, six of the 15 reported at least one unexplained drop in 
athletic performance during the competitive season lasting three weeks or longer. Though not 
conclusive in and of itself, a lasting drop in athletic performance is one diagnostic index for OTS 
[1]. Our study examined differences in oxidative stress/status markers in athletes who reported at 
least one unexplained drop in performance during a competition season and those who did not. 
We sampled participants at two different times of the year: 1) in the middle of the competitive 
season; and 2) following one month of recovery in the post-season. We hypothesized that those 
who reported a drop in performance would display significantly greater oxidative stress than 
those who did not. Furthermore, we hypothesized that those who experienced no drop in
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performance would show lower oxidative stress in the post-season condition because oxidative 
stress is associated with muscle fatigue [1]. Analyzing resting OSM values from mid-season and 
post-season recovery is a comparison few studies have undertaken. These data will add to the 
body of knowledge of OSMs during periods of exercise and recovery.
Methods
The study protocol was approved by the Institutional Review Board of the University of 
Alaska Fairbanks (UAF) (#838437-3). Following a thorough description of the study, including 
risks and benefits, 15 members of the UAF intercollegiate cross country ski team gave their 
informed consent to participate prior to data collection. The skiers were training for, and 
competing in, National Collegiate Athletic Association (NCAA) Division-I regional and national 
championship events. The group consisted of eight males and seven females (Table 3.1). All 
participants had been training for ten to twenty hours per week for no fewer than three months 
prior to sample collection. The first collection took place in early February, the middle of the 
competition season (mid-season). The second collection took place in late April, approximately 
four weeks following the conclusion of the competition season (post-season recovery). All 
samples were collected at least 15 hours post-exercise.
Participants completed the International Physical Activity Questionnaire (IPAQ) Short 
Form with instructions from a researcher at both data collection dates. Data from the 
questionnaires were cleaned and analyzed according to the IPAQ Guidelines for Data Processing 
and Analysis. A questionnaire to determine hours of athletic training and sport performance 
history was also administered at mid-season and post-season sampling.
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Participants fasted for 12 hours prior to each blood draw, mid- and post-season, with 
nothing consumed except water. Blood was obtained via venipuncture by a registered nurse 
trained in phlebotomy. 17.5 mL of blood was drawn per participant into three tubes: 4 mL, 3.5 
mL, and 10 mL. The 4 mL and 3.5 mL EDTA tubes were sent to an outside lab (Quest 
Diagnostics, Madison, NJ) for analysis while samples collected in the 10 mL EDTA tubes were 
centrifuged, aliquoted into 0.5 mL tubes, and flash-frozen within 30 minutes of sample 
collection. The resulting serum was stored at -80° C for future analyses.
Plasma samples were analyzed for superoxide dismutase (SOD) (Cayman Chemical, Ann 
Arbor, MI), nitrotyrosine^, 4-hydroxynonenal^ (HNE), and nitric oxide^ (NOX) (via nitrite and 
nitrate) (^Cell Biolabs, San Diego, CA) according to manufacturer’s instructions.
A power analysis prior to study commencement indicated that a minimum of 12 
participants would be necessary for validity. Statistical analysis was performed with Graphpad 
Prism (version 5, Graphpad Software, Inc.). Normality of data sets was determined using the 
D ’Agostino & Pearson omnibus test. If normal distribution for a particular set was found, data 
were compared with a paired t-test. If data were not normally distributed, sets were compared 
with the Wilcoxon matched-pairs signed rank test. Unpaired data were analyzed with the Mann- 
Whitney test. Outliers were identified with the extreme studentized deviate method (Grubbs’ 
test). Significant differences are reported at P < 0.05. All error is reported as standard error of 
the mean (± SEM).
We did not have adequate sample volume from two participants in the mid-season 
condition for the nitrotyrosine assay. The matched samples from the post-season recovery 
condition were subsequently not used for data analysis. One data point for SOD activity in the
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mid-season condition was found to be an outlier. Neither this outlier nor its corresponding value 
from the post-season recovery condition were used in SOD analyses.
Results
The IPAQ data indicate that the participants were significantly more active in mid-season 
than during post-season recovery (Table 3.1). Six reported experiencing at least one period of 
unexplainable, reduced athletic performance lasting at least three consecutive weeks during the 
season. The remaining nine reported no such drop in performance.
No significant difference in mean HNE concentration between mid-season (95.77 pg/mL ± 
26.68) and post-season recovery (120.9 ± 27.22) was detected. Among the six participants who 
reported a drop in performance (6D), there was no significant difference between mid-season 
(143.1 ± 36.12) and post-season recovery (197.5 ± 22.79). There was no significant difference in 
concentrations between mid-season (64.19 ± 34.94) and post-season recovery (69.80 ± 33.59) for 
the nine participants who did not report a drop in performance (9ND). In the mid-season 
condition, there was no significant difference between 6D (127.1 ± 43.09) and 9ND (74.91 ± 
34.15). In the post-season recovery condition, HNE concentration for 6D (197.5 ± 22.79) was 
significantly higher than 9ND (69.80 ± 33.59) (Figure 3.1).
Our analysis of NOX through nitrite (NO2") and nitrate (NO3") concentration revealed no 
significant difference in mean values between mid-season (21.35 pM ± 3.331) and post-season 
(20.59 ± 3.308). In the 6D group there was no significant difference between mid-season (23.44 
± 7.644) and post-season (24.61 ± 6.908). Data of 9ND showed no significant difference 
between mid-season (19.96 ± 2.723) and post-season (17.91 ± 3.130). In the mid-season, there 
was no significant difference between 6D (23.44 ±7.644) and 9ND (19.96 ± 2.723). In the post-
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season, there was no significant difference between 6D (24.61 ± 6.908) and 9ND (17.91 ± 
3.3130).
Nitrotyrosine analysis detected no significant difference in mean concentrations between 
mid-season (131.3 nM ± 12.31) and post-season (151.6 ± 12.60). There were no significant 
differences in 6D between mid-season (152.4 ± 23.46) and post-season (151.9 ± 17.72) nor in 
9ND between mid-season (118.2 ± 12.72) and post-season (151.4 ± 18.18). Nitrotyrosine 
concentrations between groups revealed no significant differences between 6D (152.4 ± 23.46) 
and 9ND (118.2 ± 12.72) in mid-season nor between 6D (151.6 ± 12.60) and 9ND (151.4 ± 
18.18) in the post-season.
Analysis of SOD revealed significantly lower activity in mid-season (0.02065 U/mL ±
0.006656) than post-season (0.04459 ± 0.005860) (Figure 3.2). Among 6D, there was 
significantly lower SOD activity in mid-season (0.01241 ± 0.006469) than post-season (0.05048 
± 0.004688) (Figure 3.3). Analysis of 9ND exhibited no significant difference between mid­
season (0.02385 ± 0.009359) activity and post-season (0.04326 ± 0.009059). In mid-season, 6D 
(0.01241 ± 0.006469) and 9ND (0.02385 ± 0.009359) displayed no significant difference. In 
post-season, no significant difference was found between 6D (0.05048 ± 0.004688) and 9ND 
(0.04326 ± 0.009059).
Discussion
Production of reactive oxygen species (ROS) and reactive nitrogen species (RNS) is 
ubiquitous with human life [10]. Numerous mechanisms, both endogenous and exogenous, 
contribute to ROS and RNS production. Primary sources of endogenous ROS include 
mitochondria [11], peroxisomes, endoplasmic reticulum, and phagocytic cells [12]. Exogenous
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sources include air pollution, radiation, alcohol, tobacco, heavy metals, transition metals, 
pesticides, industrial solvents, and certain drugs such as halothane (anesthetic) and 
acetaminophen (analgesic/fever reducer) [12]. Relative to exercise, mitochondrial respiration is 
the most important production mechanism for free radicals. Electrons “leak” from the electron 
transport chain via semiquinone anion, namely in complex I and complex III, and join molecular 
oxygen to form superoxide ion radical [12]. The non-enzymatic nature of ROS production 
through mitochondrial respiration means that at a higher metabolic rate more ROS is produced 
[12]. A “crucial balance” between ROS and RNS production and antioxidant defense may play 
an important role in endogenous disease prevention [10]. Oxidative stress from exercise and/or 
environmental toxins can cause a disruption in this crucial balance.
A healthy system will overcome oxidative stress through endogenous and exogenous 
antioxidants. A normal return to homeostasis typically occurs with isolated or short-term 
oxidative stress. For example, regular bouts of moderate exercise will initially increase ROS and 
RNS. Homeostasis will be achieved, however, if the body adjusts to greater demands on 
mitochondrial respiration. As such, the “crucial balance” will be reclaimed. However, if 
oxidative stress outstrips the body’s ability to adjust, by frequency and/or magnitude, disease 
may follow. In the case of endurance athletes, OTS may result [1]. ROS and RNS induced by 
oxidative stress have been linked to diabetes mellitus (DM), neurodegenerative diseases, cancer, 
cardiovascular diseases (CVD), cataract lenses, rheumatoid arthritis, and asthma [12]. Abnormal 
inflammation, a condition associated with a series of risk factors for metabolic diseases including 
DM, CVD, obesity [13], and rhabdomyolysis [14], is closely associated with oxidative stress and 
is a central pillar of the cytokine theory of OTS [1].
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Lipid peroxidation is characterized by the oxidation of lipid molecules by free radicals. 
Polyunsaturated fatty acid residues of phospholipids in cellular lipid membranes are particularly 
vulnerable to peroxidation [12]. Through a cascade of events including the formation of a lipid 
radical (U), then a peroxy radical (LOO^), the primary product of lipid peroxidation is formed, 
lipid hydroperoxides (LOOH). In addition to LOOH, several secondary products are formed 
including HNE, “ .. .a major bioactive marker of lipid peroxidation...” [15]. Our data indicate 
that the group of participants who experienced at least one decline in athletic performance lasting 
at least three weeks during the competitive season had significantly higher mean HNE 
concentration than those who did not experience such a decline (Figure 3.1). Higher HNE 
concentration suggests a higher degree of lipid peroxidation and cellular damage in the 6D group 
than the 9ND group even after a one-month recovery period.
A vasodilator produced in epithelial cells, NOX reacts quickly with superoxide anion (O2^ ‘) 
to form a powerful and toxic oxidant, peroxynitrite (ONOO-), continuing the oxidative cascade 
[16]. While NOX plays a critical role in mitochondrial respiration, excess NOX can mediate 
oxidative damage and may downregulate energy production [17]. Due to the short half-life of 
NOX, quantification of NOX in samples is often performed by measuring its final products, NO2- 
and NO 3-. NOX is the only known biological molecule that, at high enough concentration, can 
outcompete endogenous SOD for O2U We found no significant differences in NO2- and NO3" 
concentration in any of our comparisons suggesting that endogenous and exogenous O2^ ‘ 
scavengers may have outpaced ONOO- production.
Interaction between the amino acid tyrosine and ONOO- yields nitrotyrosine, a marker of 
nitrative stress and inflammation [18]. Protein-bound nitrotyrosine is present in a wide range of 
diseases with an inflammatory element including cardiovascular disease and diabetes [19]. Our
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data revealed no significant difference in mean concentration of nitrotyrosine between mid­
season and post-season conditions for the entire group, 6D, and 9ND. No significant differences 
were found between 6D and 9ND in either condition. These findings suggest that oxidative 
protein damage may not have exceeded the ability to mitigate such damage.
O2" is toxic and, unless an imbalance exists, is dismutated immediately by SOD to form 
hydrogen peroxide (H2O2) which, in turn, is reduced to H2O by catalases, glutathione 
peroxidases, and peroxiredoxins [20]. We tested for SOD activity as it “ .. .is a first line of 
defense against toxicity of superoxide anion radicals” [20]. SOD from plasma was used as an 
oxidative stress biomarker although this may not actually reflect exact oxidation rates at the 
cellular level. Plasma levels are an accepted marker for oxidative stress analysis [9, 21]. Total 
SOD activity was measured which included for all three SOD metalloenzymes: cytosolic (SOD 
1), mitochondrial (SOD 2), and extracellular (SOD 3). Mean SOD activity was significantly 
lower in mid-season as compared to post-season (Figure 3.2). For the group of participants who 
reported a drop in athletic performance, mean SOD activity was also significantly lower in mid­
season as compared to post-season (Figure 3.3). For the overall group, SOD activity doubled in 
the post-season while for the 6D group the activity increased by a factor of four. The SOD 
activity for the entire group and for 6D contrasts with the mean SOD activity for 9ND which was 
not significantly different between mid-season and post-season. The 6D group was driving the 
mean SOD activity values and statistical significance for the entire group.
While it is clear that SOD activity for 6D was higher in the post-season recovery condition, 
there are several possible explanations. Higher SOD activity in 6D may indicate that a greater 
increase in O2^ ‘ production has occurred. Typically, increased production of O2^ ‘ takes place 
during exercise or periods of illness. All six participants of the 6D group reported experiencing
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at least one drop in performance lasting three weeks or longer during the competitive cross 
country ski season. It is unclear if  the drop in performance is the only factor that accounts for the 
higher SOD activity in the post-season. Muscle damage and associated inflammation could 
potentially explain the increase in endogenous plasma antioxidant activity. Why SOD activity 
increased in the post-season and not in the middle of the competition season when stress levels, 
presumably, were higher would need explanation. What is clear from the SOD activity data is 
that members of the 6D group had something from which to recover. More extensive physical 
and biochemical examination would be beneficial during the season.
The SOD activity meshes somewhat with HNE data. In the post-season recovery condition, 
the 6D mean HNE concentration is over twice as high as the 9ND mean and significantly 
different (Figure 3.1). Higher SOD activity suggests that participants in the 6D group may have 
been experiencing higher lipid oxidation than participants in the 9ND group in the post-season 
recovery condition. The SOD activity discrepancy would support the notion that SOD activity 
was higher in 6D in the post-season due to oxidative stress. It is problematic, however, that there 
were no other significant differences in mean HNE concentrations in any of the other four 
comparisons. The sensitivity and relatively high level of standard error associated with each 
mean may explain at least part of this question. There are no extensive studies showing that the 
biomarkers actually correlate. It is likely that a larger sample size would clarify the seeming 
inconsistency; however, these larger studies present logistical challenges.
Our study identified six participants who displayed at least one athletic performance 
symptom associated with OTS. Samples from the six participants revealed higher SOD activity 
in the post season. The samples also displayed higher HNE concentration as compared to 9ND 
in the post-season, which is consistent with oxidative stress for the 6D group. This study
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provides additional support to the oxidative stress hypothesis of OTS. It also suggests that 
athletes may benefit from regular monitoring of markers of oxidative stress. A more robust 
sample size with a project design that includes quarterly sampling for an entire year should 
advance the understanding of the links between oxidative stress and athletic performance.
Acknowledgements
Research reported in this publication was supported by the National Institute of General 
Medical Sciences of the National Institutes of Health under Award Numbers UL1GM118991, 
TL4GM118992, or RL5GM118990. The content is solely the responsibility of the authors and 
does not necessarily represent the official views of the National Institutes of Health. We thank 
Scarlett Hopkins of the Center for Alaska Native Health Research and Terri Berrie of the 
University of Alaska Fairbanks (UAF) Student Health and Counseling Center for assistance with 
sample collection. Thank you to members of the University of Alaska Fairbanks Ski Team for 
volunteering to participate. Finally, we thank the Biomedical Learning and Student Training 
program at UAF for financial and logistical support.
Conflicts of Interest
The authors have no conflicts of interest to report. The lead author had coached some of the 
volunteer participants a few years prior to the commencement of this study. The lead author was 
not coaching at the time of participant recruitment nor during any part of the study. In addition, 
the lead author was not involved in the administration of the cognitive function tests. The results 
of this study are presented clearly, honestly, and without fabrication, falsification, or 
inappropriate data manipulation.
75
1. Kreher JB, Schwartz JB. Overtraining syndrome: a practical guide. Sports health. 
2012;4:128-38.
2. Meeusen R, Duclos M, Foster C, Fry A, Gleeson M, Nieman D, Raglin J, Rietjens G, 
Steinacker J, Urhausen A, European College of Sport S, American College of Sports M. 
Prevention, diagnosis, and treatment of the overtraining syndrome: joint consensus statement of 
the European College of Sport Science and the American College of Sports Medicine. Medicine 
and science in sports and exercise. 2013;45:186-205.
3. Le Meur Y, Hausswirth C, Natta F, Couturier A, Bignet F, Vidal PP. A multidisciplinary 
approach to overreaching detection in endurance trained athletes. Journal of applied physiology. 
2013;114:411-20.
4. MacKinnon LT. Special feature for the Olympics: effects of exercise on the immune system: 
overtraining effects on immunity and performance in athletes. Immunology and cell biology. 
2000;78:502-9.
5. Urhausen A, Gabriel HH, Weiler B, Kindermann W. Ergometric and psychological findings 
during overtraining: a long-term follow-up study in endurance athletes. International journal of 
sports medicine. 1998;19:114-20.
6. Meeusen R, Nederhof E, Buyse L, Roelands B, de Schutter G, Piacentini MF. Diagnosing 
overtraining in athletes using the two-bout exercise protocol. British journal of sports medicine. 
2010;44:642-8.
7. Meeusen R, Piacentini MF, Busschaert B, Buyse L, De Schutter G, Stray-Gundersen J. 
Hormonal responses in athletes: the use of a two bout exercise protocol to detect subtle 
differences in (over)training status. European journal of applied physiology. 2004;91:140-6.
References
76
8. Tanskanen M, Atalay M, Uusitalo A. Altered oxidative stress in overtrained athletes. J Sports 
Sci. 2010;28:309-17.
9. Margonis K, Fatouros IG, Jamurtas AZ, Nikolaidis MG, Douroudos I, Chatzinikolaou A, 
Mitrakou A, Mastorakos G, Papassotiriou I, Taxildaris K, Kouretas D. Oxidative stress 
biomarkers responses to physical overtraining: implications for diagnosis. Free Radic Biol Med. 
2007;43:901-10.
10. Lachance PA, Nakat Z, Jeong WS. Antioxidants: an integrative approach. Nutrition. 
2001;17:835-8.
11. Pesta D, Roden M. The Janus Head of Oxidative Stress in Metabolic Diseases and During 
Physical Exercise. Curr Diab Rep. 2017;17:41.
12. Phaniendra A, Jestadi DB, Periyasamy L. Free radicals: properties, sources, targets, and their 
implication in various diseases. Indian J Clin Biochem. 2015;30:11-26.
13. Keane KN, Cruzat VF, Carlessi R, de Bittencourt PI, Jr., Newsholme P. Molecular Events 
Linking Oxidative Stress and Inflammation to Insulin Resistance and beta-Cell Dysfunction.
Oxid Med Cell Longev. 2015;2015:181643.
14. Hamel Y, Mamoune A, Mauvais FX, Habarou F, Lallement L, Romero NB, Ottolenghi C, de 
Lonlay P. Acute rhabdomyolysis and inflammation. J Inherit Metab Dis. 2015;38:621-8.
15. Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling 
mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 
2014;2014:360438.
16. Jin H, Webb-Robertson BJ, Peterson ES, Tan R, Bigelow DJ, Scholand MB, Hoidal JR, 
Pounds JG, Zangar RC. Smoking, COPD, and 3-nitrotyrosine levels of plasma proteins. Environ 
Health Perspect. 2011;119:1314-20.
77
17. Tengan CH, Rodrigues GS, Godinho RO. Nitric oxide in skeletal muscle: role on 
mitochondrial biogenesis and function. Int J Mol Sci. 2012;13:17160-84.
18. Vasilaki A, Simpson D, McArdle F, McLean L, Beynon RJ, Van Remmen H, Richardson 
AG, McArdle A, Faulkner JA, Jackson MJ. Formation of 3-nitrotyrosines in carbonic anhydrase 
III is a sensitive marker of oxidative stress in skeletal muscle. Proteomics Clin Appl. 2007;1:362- 
372.
19. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. 
Physiological reviews. 2007;87:315-424.
20. Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, 
and diseases. Antioxid Redox Signal. 2011;15:1583-606.
21. Samjoo IA, Safdar A, Hamadeh MJ, Raha S, Tarnopolsky MA. The effect of endurance 
exercise on both skeletal muscle and systemic oxidative stress in previously sedentary obese 
men. Nutr Diabetes. 2013;3:e88.
78
T able 3.1 Participant Characteristics
N Age
Body fat (%) Total METf (min/wk)
Mid-season Post-season Mid-season Post-season
Total 15 20.4 ± 1.64 NA NA
5335 
± 427
3185** 
± 446
Male 8 20.6 ± 1.92
12.0 
± 0.387
11.9 
± 0.573
4903 
± 449
3447 
± 735
Female 7 20.1 ± 1.35
29.4 
± 2.22
28.7 
± 2.29
5830 
± 754
2886* 
± 495
Age, percent body fat, and MET minutes/week for all participants, males, and females. Mean 
values ± SEM. ^Metabolic Equivalent Task. **p<0.01 *p<0.05
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Figure 3.1. Post-Season Plasma HNE. In the post-season recovery condition, mean plasma HNE 
concentration was significantly higher (p<0.05) for participants who reported at least one 
unexplainable drop in athletic performance lasting three weeks or longer during the competition 
season (6D) (197.5 qg/mL ± 22.79) than for participants who did not report such a drop (9ND) 
(69.80 qg/mL ± 33.59).
Figure 3.2. Comparison of Superoxide Dismutase Mid-Season and Post-Season. Participants 
displayed significantly higher (p<0.05) SOD activity in the post-season recovery condition 
(0.02065 U/mL ± 0.006477) as compared to the mid-season condition (0.04459 U/mL ±
0.005860).
Figure 3.3. Comparison of Superoxide Dismutase of Athletes Reporting a Drop in Performance. 
Mean SOD activity for participants who reported at least one unexplainable drop in athletic 
performance lasting three weeks or longer during the competition season (6D) was significantly 
higher (p<0.05) in the post-season condition (0.05048 U/mL ± 0.004688) than in the mid-season 
condition (0.01241 U/mL ± 0.006469).
Figure Captions
80
Figure 3.1
Post-Season Plasma HNE
Figure 3.2
SOD Activity
81
U/
mL
 
(± 
SE
M
)
Figure 3.3
SOD Activity, 6D
82
The studies herein revealed several clues that may provide valuable insight into the 
etiology of overtraining syndrome (OTS). Collegiate endurance athletes are more likely to be 
vitamin D insufficient or deficient than their sedentary counterparts. Collegiate cross country ski 
racers in the circumpolar North are unlikely to maintain even a minimum level of vitamin D 
adequacy during the winter’s competition season. Furthermore, vitamin D levels of these skiers 
are likely to drop in the post-season, recovery period despite higher levels of sunlight. Cognitive 
function is significantly higher in the post-season than during the competition season. Finally, 
those who experienced a drop in performance during the competition season are more likely to 
show signs of oxidative stress. Despite these interesting findings it remains unclear if  any of 
these are causes of, or effects from, OTS. Regardless, the association of some of these markers 
with underperformance could help create a screening profile to determine which athletes are at 
the greatest risk for developing OTS. At the very least, the results of these collective 
manuscripts have revealed biomarkers of interest that warrant further investigation.
In order to investigate further, I propose two research projects. The first uses a unique 
athlete model for markers associated with OTS. Sprint and distance sled dogs have been 
recognized as some of the top athletes in the world regardless of species. With a maximum 
oxygen uptake (V O2 max) approaching 240 mL/kg/min [1] and the ability to run at a speed of 
approximately 32 km/h (20 mph) for up to 75 minutes (+/-) per session, it is not hyperbole to say 
that the sprint-distance sled dog may be the fittest animal ever tested for aerobic power. The 
fittest human athletes do not even begin to approach the canine level of oxygen consumption. At 
the elite level, cross country skiers are considered to be among the fittest athletes. Medal
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winners at events such as the Winter Olympic Games and World Championships have V O2 max 
levels of ~80-90 mL/kg/min for men and approaching ~75 mL/kg/min for women [2].
Distance sled dogs, those competing in events such as the 1,600 km (1,000 mi) Iditarod 
Trail Sled Dog Race, are bred for extreme weather conditions, longer runs, and multiple days of 
running. Distance dogs run at a slower pace than sprint dogs, though they run for hours and 
hours, day after day, whereas most sprint competitions are two or three days events with 15-75 
minutes of effort per session. Distance dogs expend of over 11,000 kcal per day during a multi­
day event [3], while an ultra-triathletes expend ~4200 kcal per day when completing five 
Ironman-distance triathlons in five consecutive days [4]. When adjusted for body mass, the 
distance dog expends approximately eight times more energy than the human during multi-stage, 
endurance races.
Most sled dogs from competitive teams are raised, trained, fed, and cared for in 
controlled conditions. Typically, dogs from one kennel -  particularly those on the same team 
within a kennel -  receive the same diet, are trained the same amount and in the same manner, 
and receive the same rest and recovery periods. Sled dogs do not have to cope with the same 
external factors as their human athlete counterparts. In addition to sports training, human 
athletes must contend with a variety of pressures including jobs, family dynamics, relationships, 
societal expectations, media, schoolwork, etc. These additional stressors add to the overall 
complexity of strain which may contribute to non-functional overreaching or overtraining. Sled 
dogs are also bred for conformational similarity to optimize performance. Thus, a high level of 
genetic homogeneity is achieved in a particular kennel. Competitive sled dogs, whether they be 
sprint dogs or distance dogs, are therefore uniquely suited to serve as a model for specific aspects 
of training and performance in human endurance athletes.
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The notion that a researcher would be able to quantify and record complete dietary 
intake, health status, training regimen, and athletic performance over weeks and months in one 
single athlete is almost unheard of. Totalitarian states with unethical, elite sports programs 
notwithstanding, it would be practically impossible to reach this comprehensive level of 
monitoring for a group of 20-40 human athletes. This level of monitoring is, however, precisely 
what is possible by studying sled dogs from competitive racing kennels. With a high level of 
precision and accuracy, researchers are able to monitor the best endurance athletes in the world.
I propose that competitive sled dogs, from both sprint and distance kennels, be used for 
studying OTS. No dogs should ever be purposely overtrained. By monitoring dogs from the 
start of a new competitive cycle (May or June) through the completion of competition season 
(March or April) we may be able to identify those whose performance has dropped for no readily 
apparent reason. Dogs that have an injury or other condition (age, pregnancy, heat cycle, etc.) 
that explains underperformance would be excluded. Typically, an underperforming dog is 
“dropped” from the team and replaced by another. By examining biomarkers from all dogs from 
a kennel on a monthly basis, researchers may be able to identify differences, subtle or concrete, 
between dropped dogs and those performing “normally” or up to expectation. While the 
underperformance may not manifest itself until the racing season, clues as to why a dog reached 
that point may be available from data collected in the summer and fall. The proverbial “straw 
that broke the camel’s back” may have little to do with the reason that a dog reached the point of 
underperformance and hence was dropped from a team. The answer is more likely to come from 
the months leading up to that circumstance. A sled dog study combining thorough record 
keeping and regular sampling may provide clues for further OTS research with human endurance 
athletes.
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The second project is also longitudinal and requires human athletes as research 
participants. It is based on the same principle as the sled dog study. What is different between 
those human athletes whose performance improves over time and those who, despite training in 
an “appropriate” way, find their performance declining? While we would like to keep “all things 
equal” for athletes in the study, this concept is utterly impossible in practical terms. We can, 
however, monitor critical components to serve as markers for health, mental stress, physical 
stress, and performance.
I propose that we recruit 40 (20 = M, 20 = F) elite, cross country skiers from clubs 
around the world located at a similar latitude who are not experiencing a period of 
underperformance. We will sample and test athletes five times through the annual training cycle: 
1) beginning of the new, training cycle (May 1); 2) following the summer training macrocycle 
(August 30); 3) prior to the racing season (November 1); 4) immediately following the 
competitive season (April 8); and 5) following the recovery period (April 30). Blood samples 
would be tested for vitamin D, inflammatory cytokines, markers of oxidative stress, and a 
general chemistry/health panel. The Purdue Pegboard Test and the Profile of Mood States test 
would be administered along with questionnaires regarding training load, health, and athletic 
performance. Finally, participants would complete a submaximal exercise test with a blood 
lactate profile to evaluate aerobic fitness.
We will establish baseline values as well as values for athletes progressing at a “normal” 
rate of performance improvement. We will compare baseline values and normal progression 
values with themselves over time as well as against participants who experience a plateau or 
drop in athletic performance and/or other symptoms associated with OTS. Longitudinal 
methodology along with a robust sample size will allow us to pinpoint abnormalities that may
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have been present before the onset of OTS symptoms. This design will give us a better 
understanding of what tests to include in a pre-OTS screening panel. Information from the panel 
could then be used to help athletes and trainers alike make intelligent choices about training load, 
recovery periods, and overall lifestyle.
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